Infectious Disease - HIV/Immunodeficiency News & Articles

481 SWIFT: Prospective 48-Week Study to Evaluate Efficacy and Safety of Switching to Emtricitibine/Tenofovir From Lamivudine/Abacavir in Virologically Suppressed HIV-1 Infected Patients on a Boosted Protease Inhibitor Containing Antiretroviral Regimen Clinical Infectious Diseases, April 2, 2013    Clinical Article

482 Therapeutic Vaccination Expands and Improves the Function of the HIV-specific Memory T Cell Repertoire The Journal of Infectious Diseases, April 2, 2013    Clinical Article

483 Entry Inhibitors and their use in the Treatment of HIV-1 Infection Antiviral Research , April 2, 2013    Clinical Article

484 'Remote FASH' tele-sonography–a novel tool to assist diagnosing HIV-associated extrapulmonary tuberculosis in remote areas Acta Tropica, April 2, 2013    Clinical Article

485 Two New Tryptophan Derivatives from the Seed Kernels of Entada rheedei: Effects on Cell Viability and HIV Infectivity Fitoterapia, April 2, 2013    Clinical Article

486 Assessing Barriers and Facilitators of Implementing an Integrated HIV Prevention and Property Rights Program in Western Kenya AIDS Education and Prevention, April 2, 2013    Clinical Article

487 Reproductive patterns and fertility wishes among HIV-infected patients: survey from six outpatient clinics in Denmark International Journal of Infectious Diseases, April 2, 2013    Clinical Article
Exclusive Author Commentary

488 Extrapulmonary mycobacterial infections in a cohort of HIV-positive patients: ultrasound experience from Vicenza, Italy Infection, April 2, 2013    Clinical Article

489 Scaling up prevention of mother-to-child HIV transmission programs in sub-Saharan African countries: a multilevel assessment of site-, program- and country-level determinants of performance Full Text BMC Public Health, April 2, 2013    Review Article

490 Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected and uninfected women from Brazil Journal of Clinical Virology, April 2, 2013    Clinical Article

491 Infection Rate Following Total Joint Arthroplasty in the HIV Population Journal of Arthroplasty, April 2, 2013    Review Article

492 Posttraumatic Stress Symptoms Among Adults Caring for Orphaned Children in HIV-Endemic South Africa AIDS and Behavior, April 2, 2013    Clinical Article

493 Contribution of genetic background, traditional risk factors and HIV-related factors to coronary artery disease events in HIV-positive persons Clinical Infectious Diseases, April 1, 2013    Clinical Article

494 Increased FDG uptake in association with reduced extremity fat in HIV patients Antiviral Therapy , April 1, 2013    Clinical Article

495 Pharmacokinetics and 48-week safety and efficacy of generic lopinavir/ritonavir in Thai HIV-infected patients Antiviral Therapy , April 1, 2013    Clinical Article

496 Systemic immune activation and microbial translocation in dual HIV/TB infected subjects The Journal of Infectious Diseases, April 1, 2013

497 Molecular and pathologic insights from latent HIV-1 infection in the human brain Neurology, April 1, 2013    Continuing Medical Education

498 Vitamin D deficiency and its relation to bone mineral density and liver fibrosis in HIV–HCV coinfection Antiviral Therapy , April 1, 2013    Clinical Article

499 Nurses knowledge and skills in providing mental health care to people living with HIV/AIDS in Malawi Journal of Psychiatric and Mental Health Nursing, April 1, 2013    Clinical Article

500 Microbial translocation induces an intense proinflammatory response in visceral leishmaniasis patients co-infected with HIV-1 The Journal of Infectious Diseases, April 1, 2013    Clinical Article

1 A Conceptual Framework for Understanding Chronic Pain in Patients with HIV Pain Practice, April 5, 2013

2 The Cost and Impact of Scaling Up Pre-exposure Prophylaxis for HIV Prevention: A Systematic Review of Cost-Effectiveness Modelling Studies PLoS Medicine, March 15, 2013    Free full text    Evidence Based Medicine

3 Is Frequent CD4+ T-Lymphocyte Count Monitoring Necessary for Persons With Counts >=300 Cells/{micro}L and HIV-1 Suppression Clinical Infectious Diseases, April 11, 2013

4 Cost-effectiveness of efavirenz vs rilpivirine in HIV patients initiating first-line combination antiretroviral therapy Journal of Medical Economics , April 12, 2013

5 Contribution of genetic background, traditional risk factors and HIV-related factors to coronary artery disease events in HIV-positive persons Clinical Infectious Diseases, April 1, 2013

6 A Pill for HIV Prevention: Deja Vu All Over Again Clinical Infectious Diseases, March 28, 2013

7 Durable Efficacy and Safety of Raltegravir Versus Efavirenz When Combined With Tenofovir/Emtricitabine in Treatment-Naive HIV-1–Infected Patients: Final 5-Year Results From STARTMRK Journal of Acquired Immune Deficiency Syndromes, April 16, 2013

8 SWIFT: Prospective 48-Week Study to Evaluate Efficacy and Safety of Switching to Emtricitibine/Tenofovir From Lamivudine/Abacavir in Virologically Suppressed HIV-1 Infected Patients on a Boosted Protease Inhibitor Containing Antiretroviral Regimen Clinical Infectious Diseases, April 2, 2013

9 Faith-Based HIV Prevention and Counseling Programs: Findings from the Cincinnati Census of Religious Congregations AIDS and Behavior, April 10, 2013

10 Effects of Smoking on Non-AIDS-Related Morbidity in HIV-Infected Patients Clinical Infectious Diseases, April 29, 2013

11 Cobicistat: A New Boost for the Treatment of Human Immunodeficiency Virus Infection Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, March 13, 2013

12 Hcv clearance from saliva of hiv-hcv coinfected patients on treatment with interferon plus ribavirin Oral Diseases , April 15, 2013    Evidence Based Medicine

13 CD4 Count Slope and Mortality in HIV-Infected Patients on Antiretroviral Therapy: Multicohort Analysis From South Africa Journal of Acquired Immune Deficiency Syndromes, April 12, 2013    Review Article

14 A Randomized Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate for Initial Treatment of HIV-1 Infection: Analysis of Week 96 Results Journal of Acquired Immune Deficiency Syndromes, April 17, 2013

15 Trends and Disparities in Antiretroviral Therapy Initiation and Virologic Suppression Among Newly Treatment-Eligible HIV-Infected Individuals in North America, 2001-2009 Clinical Infectious Diseases, February 26, 2013

16 Monocyte and Myeloid Dendritic Cell Activation Occurs Throughout HIV Type 2 Infection, an Attenuated Form of HIV Disease The Journal of Infectious Diseases, April 12, 2013

17 Rilpivirine vs. efavirenz in HIV-1 patients with baseline viral load 100,000 copies/ml or less: week 48 phase III analysis AIDS, March 21, 2013

18 Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis The Lancet Infectious Diseases, April 18, 2013

19 Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs The Lancet, March 29, 2013

20 Immune control of HIV-1 reservoirs Current Opinion in HIV and AIDS, April 23, 2013